Fresenius Medical Care (NYSE:FMS) Research Coverage Started at Berenberg Bank

Berenberg Bank began coverage on shares of Fresenius Medical Care (NYSE:FMS) in a research report sent to investors on Wednesday morning, Marketbeat reports. The firm issued a buy rating and a $25.60 price objective on the stock.

A number of other equities analysts also recently issued reports on FMS. Truist Financial increased their price objective on shares of Fresenius Medical Care from $22.00 to $23.00 and gave the company a “hold” rating in a research note on Monday, October 7th. StockNews.com initiated coverage on Fresenius Medical Care in a research note on Friday, November 1st. They set a “strong-buy” rating for the company. One investment analyst has rated the stock with a sell rating, two have given a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $24.30.

Fresenius Medical Care Trading Down 0.1 %

Shares of NYSE FMS traded down $0.03 during mid-day trading on Wednesday, reaching $21.30. The company had a trading volume of 229,661 shares, compared to its average volume of 301,953. The stock has a market cap of $12.50 billion, a price-to-earnings ratio of 17.59, a price-to-earnings-growth ratio of 1.02 and a beta of 0.91. The business’s 50-day moving average is $20.46 and its 200-day moving average is $20.23. Fresenius Medical Care has a 52 week low of $16.86 and a 52 week high of $22.76. The company has a current ratio of 1.37, a quick ratio of 1.09 and a debt-to-equity ratio of 0.42.

Institutional Trading of Fresenius Medical Care

Hedge funds and other institutional investors have recently bought and sold shares of the stock. ORG Partners LLC purchased a new stake in Fresenius Medical Care during the 1st quarter worth approximately $110,000. SG Americas Securities LLC raised its position in shares of Fresenius Medical Care by 50.0% in the first quarter. SG Americas Securities LLC now owns 15,228 shares of the company’s stock valued at $294,000 after buying an additional 5,078 shares during the last quarter. QRG Capital Management Inc. boosted its position in Fresenius Medical Care by 19.5% during the first quarter. QRG Capital Management Inc. now owns 54,363 shares of the company’s stock worth $1,048,000 after acquiring an additional 8,870 shares during the last quarter. SageView Advisory Group LLC purchased a new stake in Fresenius Medical Care during the 1st quarter valued at about $127,000. Finally, Signaturefd LLC raised its holdings in Fresenius Medical Care by 8.4% in the 2nd quarter. Signaturefd LLC now owns 8,713 shares of the company’s stock valued at $166,000 after acquiring an additional 672 shares during the last quarter. 8.25% of the stock is owned by institutional investors and hedge funds.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.